Merry Christmas and Happy Holidays to everyone! I expect good news in the new year. I believe FDA approval is in the cards for UNVC investors this coming year, and suspect we are already in phase two or three as we speak. I also suspect Dr Dalton chose to trial in Israel to keep away from prying eyes and will get approval in Europe first. However, the FDA is currently reviewing nano-emulsified CBD in this country, so it could be that Doc has all bases covered. EnvisionRX could bring an explosion of excitement to Univec shareholders as well. Consider for a moment that the Univec transdermal patch is actually a "platform" delivery system that can be used to deliver a multitude of medical treatments for all kinds of ailments. We all talked about PTSD, and drug addiction solutions, but think even bigger. A treatment for some forms of cancer may be in the cards, and various asthma treatments using a completely different delivery system. The future looks bright, and we may have to wear shades.


Kgem